SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment

Current Alzheimer Research

Volumn 11, Issue 8, 2014, Pages 785-791

  Zoller, Amy S ^a   Gaal, Ildiko M ^b   Royer, Christine A ^c   Locascio, Joseph J ^a   Amariglio, Rebecca E ^a,d   Blacker, Deborah ^a   Okereke, Olivia I ^a,d   Johnson, Keith A ^a,d   Sperling, Reisa A ^a,d   Rentz, Dorene M ^a,d   Marshall, Gad A ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WELLESLEY COLLEGE   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Activities of daily living; Alzheimer s disease; Clinical assessment; Clinically normal elderly; Daily functioning; Mild cognitive impairment

Indexed keywords

AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL DEMENTIA RATING; COGNITION; DAILY LIFE ACTIVITY; DEMOGRAPHY; EXECUTIVE FUNCTION; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL TASK; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; STRUCTURED INTERVIEW AND SCORING TOOL MASSACHUSETTS ALZHEIMER DISEASE RESEARCH CENTER INFORMANT REPORT; TASK PERFORMANCE; AGING; COHORT ANALYSIS; LEARNING; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RECALL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGING; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENTAL RECALL; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; ROC CURVE; VERBAL LEARNING;

EID: 84926182069     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720501108140910122220     Document Type: Article

References (33)

1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3): 263-269 (2011).
2. Sperling RA, Jack CR, Jr., Aisen PS. Testing the right target and right drug at the right stage. Sci Transl Med 3(111): 111-133 (2011).
3. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3): 270-279 (2011).
4. Marshall GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA, et al. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer’s disease. Alzheimers Dement 7(3): 300-308 (2011).
5. Morris JC. Revised Criteria for Mild Cognitive Impairment May Compromise the Diagnosis of Alzheimer Disease Dementia. Arch Neurol (2012).
6. Brown PJ, Devanand DP, Liu X, Caccappolo E. Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry 68(6): 617-626 (2011).
7. Marshall GA, Amariglio RE, Sperling RA, Rentz DM. Activities of daily living: Where do they fit in the diagnosis of Alzheimer’s disease. Neurodegener Dis Manag 2(5): 483-491 (2012).
8. Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 64(12): 1443-1450 (2007).
9. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3): 280-292 (2011).
10. Okereke OI, Copeland M, Hyman BT, Wanggaard T, Albert MS, Blacker D. The Structured Interview & Scoring Tool- Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview. Arch Neurol 68(3):343-350 (2011).
11. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43(11): 2412-2414 (1993).
12. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord 23(2): 91-101 (2009).
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189-198 (1975).
14. Pfeffer RI, Kurosaki TT, Harrah CH, Jr., Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 37(3): 323-329 (1982).
15. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 12(2): 233-239 (2000).
16. Buschke H. Cued recall in amnesia. J Clin Neuropsychol 6(4): 433-440 (1984).
17. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. Second ed. San Antonio, TX: Psychological Corporation (2000).
18. Benton AL, Hamsher KS. Multilingual apahasia examination. Iowa City, Iowa: AJA Associates (1989).
19. Johnson N, Barion A, Rademaker A, Rehkemper G, Weintraub S. The Activities of Daily Living Questionnaire: a validation study in patients with dementia. Alzheimer Dis Assoc Disord 18(4): 223-230 (2004).
20. Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, et al. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer’s disease. Am J Geriatr Psychiatry (in press) (2014).
21. Okereke OI, Pantoja-Galicia N, Copeland M, Hyman BT, Wanggaard T, Albert MS, et al. The SIST-M: predictive validity of a brief structured clinical dementia rating interview. Alzheimer Dis Assoc Disord 26(3): 225-231 (2012).
22. Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14(2): 234-244 (1978).
23. Royall DR, Lauterbach EC, Kaufer D, Malloy P, Coburn KL, Black KJ, et al. The cognitive correlates of functional status: a review from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 19(3): 249-265 (2007).
24. Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord 20(4 Suppl 3): S152-169 (2006).
25. Farias ST, Mungas D, Harvey DJ, Simmons A, Reed BR, DeCarli C. The measurement of everyday cognition: Development and validation of a short form of the Everyday Cognition scales. Alzheimers Dement 7593-601 (2011).
26. Goldberg TE, Koppel J, Keehlisen L, Christen E, Dreses- Werringloer U, Conejero-Goldberg C, et al. Performance-based measures of everyday function in mild cognitive impairment. Am J Psychiatry 167(7): 845-853 (2010).
27. Triebel KL, Martin R, Griffith HR, Marceaux J, Okonkwo OC, Harrell L, et al. Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. Neurology 73(12): 928-934 (2009).
28. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32(7): 1207-1218 (2011).
29. Marshall GA, Olson LE, Frey MT, Maye J, Becker JA, Rentz DM, et al. Instrumental activities of daily living impairment is associated with increased amyloid burden. Dement Geriatr Cogn Disord 31(6): 443-450 (2011).
30. Okonkwo OC, Alosco ML, Griffith HR, Mielke MM, Shaw LM, Trojanowski JQ, et al. Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease. Arch Neurol 67(6): 688-696 (2010).
31. Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, Tremont G. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment. Alzheimers Dement 6(5): 404-411 (2010).
32. Marshall GA, Lorius N, Locascio JJ, Hyman BT, Rentz DM, Johnson KA, et al. Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer disease spectrum. J Alzheimers Dis 41(3): 719-728 (2014).
33. Roy K, Pepin LC, Philiossaint M, Lorius N, Becker JA, Locascio JJ, et al. Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer’s disease spectrum. J Alzheimers Dis 42(1): 291-300 (2014).